Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-050238
Filing Date
2025-06-03
Accepted
2025-06-02 20:00:03
Documents
5
Period of Report
2025-06-03

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0244344-6k_ascentage.htm 6-K 12342
2 PRESS RELEASE DATED JUNE 2, 2025 ea024434401ex99-1_ascentage.htm EX-99.1 24445
3 PRESS RELEASE DATED JUNE 2, 2025 ea024434401ex99-2_ascentage.htm EX-99.2 29238
4 GRAPHIC ex99-1_001.jpg GRAPHIC 2878
5 GRAPHIC ex99-2_001.jpg GRAPHIC 2878
  Complete submission text file 0001213900-25-050238.txt   75345
Mailing Address 68 XINQING ROAD SUZHOU INDUSTRIAL PARK SUZHOU , JIANGSU F4 00000
Business Address 68 XINQING ROAD SUZHOU INDUSTRIAL PARK SUZHOU , JIANGSU F4 00000 86 512 8555 7777
ASCENTAGE PHARMA GROUP INTERNATIONAL (Filer) CIK: 0002023311 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-42484 | Film No.: 251016862
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)